Free Neurology CME | CMEList.com

 


Chronic inflammatory demyelinating polyneuropathy (CIDP): therapeutic updates, best practices, and emerging therapies Free Neurology CME Posted by...Bernard Sklar, MD.
Free Neurology CME Credit Hours...0.75.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...Healthcare professionals specializing in: neurology, internal medicine; nurse practitioners, physician assistants, nurses, and pharmacists who specialize in neurology; and those who otherwise commonly care for or clinically encounter patients with CIDP.
Educational material updated...January 19, 2018.
Expiration of CME credit...January 19, 2020.
Financial Support...CSL Behring.
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a chronic, acquired, autoimmune disorder affecting the peripheral nervous system. Symptoms of CIDP include progressive limb weakness, usually with a predilection for proximal muscles, and sensory loss and are monophasic and progress for 8 weeks or more.
After viewing Chronic inflammatory demyelinating polyneuropathy (CIDP) , you will be able to:
• Describe the pathophysiology of CIDP such that it might inform treatment mechanisms
• Identify the currently available and emerging pharmacotherapeutic treatments for management of CIDP and apply them to patient cases using evidence-based medicine
• Modify an existing treatment plan for a specific patient with CIDP to optimize safety and efficacy following non-response to therapy
• Describe non-pharmacological options to manage CIDP

A 360° Approach to Translating MS Data into Optimal Practice
Free Multiple Sclerosis CME
Posted by...Bernard Sklar, MD.
CME Credit Hours...3.0.
CME Credits Awarded by...Consortium of Multiple Sclerosis Centers.
Cost for Credit...Free.
Instruction Type...Webinar with Audio Commentary.
Target Audience... This educational initiative is intended to meet the needs of neurologists, nurses, nurse practitioners, physician assistants, rehabilitation professionals, case managers, mental health professionals, social workers and others involved in the management of patients with MS.
Educational material last updated...July 31, 2017.
CME Credit Expires...July 30, 2018.
Financial Support... Biogen and Sanofi Genzyme.
A 360° Approach to Translating MS Data into Optimal Practice focuses on practical topics, review clinical trial data with clarity and thoroughness, and incorporates cases to engage you on how this information can be used in clinical practice, for all disciplines involved in the care of patients with MS.
Upon completion of A 360° Approach to Translating MS Data into Optimal Practice, you should be better able to:
• Analyze data from clinical trials of disease modifying therapies to inform personalized treatment and monitoring of outcomes for patients with MS
• Access reliable and evidence-based resources in order to stay current with advances in the management of MS
• Integrate new and emerging information on the pathophysiology of MS, including modifiable risk factors, in the development of individualized treatment plans

Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy Free Neurology CME
Live online July 27, 2017 and available on demand through July 27, 2018.
Posted by...Bernard Sklar, MD.
Free Neurology CME Credit hours..1.0.
CME Credits Awarded by....Postgraduate Institute for Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for US-based neurologists, immunologists, physician assistants, nurse practitioners, and nurses who manage, or have an interest in managing patients with immune-mediated neuropathies.
Educational material updated...July 27, 2017.
Expiration of CME credit...July 27, 2018.
Financial Support...Genentech.
Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy emphasizes the use of IVIg in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. The presentation consists of a single lecture, Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy, with discussion by Roy L. Freeman, MD, Richard J. Barohn, MD and Kenneth C. Gorson, MD. 
After viewing Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy , you will be better able to :
• Conduct a thorough and timely evaluation and differential diagnosis of patients with chronic inflammatory demyelinating polyneuropathy.
• Devise appropriate treatment regimen for the effective management of chronic inflammatory polyneuropathy based on guidelines and clinical evidence. 

Neuropsychiatric Sequelae Virtual Curriculum Series: Agitation, Depression, and Pseudobulbar Affect Free Diabetes CME
Live online April 4, 2017 and available on demand through June 23, 2018.
Posted by...Bernard Sklar, MD.
Free Neuropsychiatry CME Credit hours..2.0.
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for US-based neurologists, psychiatrists, geriatricians, primary care clinicians and health care providers involved in the care of patients with neuropsychiatric sequelae who may be suffering from agitation as a result of Alzheimer's disease (AD).
Educational material updated...April 4, 2017.
Expiration of CME credit...June 23, 2018.
Financial Support...Avanir Pharmaceuticals, Inc.
Neuropsychiatric Sequelae Virtual Curriculum Series: Agitation, Depression, and Pseudobulbar Affect consists of two sections: Mechanisms and Management of Agitation in Alzheimer's Disease and Challenges in Managing Treatment-Resistant Depression.
After viewing Neuropsychiatric Sequelae Virtual Curriculum Series, you will be better able to :
• Identify different and various forms of agitation among patients with Alzheimer's disease (AD).
• Review proposed mechanisms underlying agitation in AD and how pharmacologic agents may affect them
• Evaluate body of evidence of current and emerging pharmacologic agents for the management of agitation/aggression in patients with AD

Treatment strategies in Hunter Syndrome Free Neurology CME
Posted by...Bernard Sklar, MD.
Free Pulmonology and Genetics CME Credit Hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost..........Free.
Instruction Type....Slide-Video Lectures.
Target Audiences....Pediatricians, neurologists, endocrinologists, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists; and any other healthcare professionals with an interest in or who may clinically encounter patients with Hunter syndrome.
Educational material last updated...June 29, 2017.
Expiration of CME credit...June 29, 2019.
Financial Support...Shire.
Hunter syndrome is an X-linked recessive genetic disease characterized by a deficiency of lysosomal enzymes responsible for the hydrolysis of glycosaminoglycans (GAGs), with males more likely to develop disease and females more likely to be carriers.
After reviewing Treatment strategies in Hunter Syndrome, you will be able to:
• Describe the importance of earlier treatment and diagnosis of Hunter syndrome in patients
• Determine the likelihood of Hunter syndrome using with established diagnosis methods, given a patient case
• Describe options available to treat Hunter syndrome and design a medical plan to treat a patient with Hunter syndrome
• Describe present barriers to care in the treatment of patients with Hunter syndrome

Updates in Migraine Headaches: Best practices and Emerging Therapies in Treatment and Prevention 
Posted by...Bernard Sklar, MD. Free Neurology CME Free Pain Management CME
Free Neurology and Pain Management CME Credit hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...Healthcare professionals who are: primary care physicians, neurologists, headache specialists, nurse practitioners, physician assistants, nurses, OB-GYN specialists, pharmacists, and those who otherwise commonly care for or clinically encounter patients who may experience migraine headache.
Educational material updated...July 20, 2016.
Expiration of CME credit...July 20, 2018.
Financial Support...AMGEN and Promius.
After viewing Updates in Migraine Headaches, you will be able to:
• Describe the prevalence of migraine symptoms and the impact that these symptoms have on efficacy of anti-migraine therapy and functional status
• Describe the sometimes variable manifestations (e.g., incidence and clinical presentation) of migraine headaches, depending on age and sex
• Recall emerging therapies for the treatment and prevention of chronic migraine headache and anticipate their place in therapy
• Support team-based learning and communication between all clinicians involved with the care of patients suffering with migraines
• Given a series of patient cases, diagnosis and treat migraine headaches by employing current treatment guidelines, using evidence-based therapy algorithms, and providing individualized approaches to care

ScientiaCME Neuropsychiatry-Neurology Free Neurology CME ScientiaCME Neurology  
Posted by...Bernard Sklar, MD.
Neurology Credit hours...3.75.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...NEUROLOGY.
CME Credit Expires...Two years after release.
Financial Support...Various commercial supporters. 

ScientiaCME Treatment strategies in Gaucher disease Free Gaucher Disease CME
CME Credit Hours...1.25.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...Cardiology, genetic disorders, hematology, oncology, orthopedics, gastroenterology, neurology and pediatrics.
Educational material updated....February 12, 2017.
Expiration of CME credit...February 12, 2019.
Financial Support...Shire.
At the conclusion of By the end of Treatment strategies in Gaucher disease, you will be able to:
• Describe the importance of appropriate GD (Gaucher Disease) diagnosis and treatment (use • for bullets)
• Determine the likelihood of GD using with established diagnosis methods, given a patient case
• Describe present therapies for the treatment of GD and the literature supporting their use
• Design a medical plan to treat a patient with GD, taking into account presently available therapies





-->